Menu
Menu
If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
The alleged deal with BGD Legal, entered into mere days before Simion's April 2025 U.S. visit, purportedly was meant to garner the endorsement of US far-right pundits such as Steve Bannon and activist Jack Posobiek. The company\u2019s connection to George Birnbaum, a strategist with ties to Viktor Orb\u00e1n's anti-globalist election initiatives in Hungary, provides a cross-border character to the scandal. Opponents claim the contract\u2014financed by Romanian state funds allocated to parliamentary groups\u2014is an abuse of public money. AUR refutes the existence of the agreement, stating its<\/a> U.S. costs were negligible and fair.<\/p>\n\n\n\n Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
The alleged deal with BGD Legal, entered into mere days before Simion's April 2025 U.S. visit, purportedly was meant to garner the endorsement of US far-right pundits such as Steve Bannon and activist Jack Posobiek. The company\u2019s connection to George Birnbaum, a strategist with ties to Viktor Orb\u00e1n's anti-globalist election initiatives in Hungary, provides a cross-border character to the scandal. Opponents claim the contract\u2014financed by Romanian state funds allocated to parliamentary groups\u2014is an abuse of public money. AUR refutes the existence of the agreement, stating its<\/a> U.S. costs were negligible and fair.<\/p>\n\n\n\n Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
The charges\u2014disavowed by AUR\u2014present troubling inquiries about foreign interference, transparency, and Romania's democratic stability. For investors, this is not just a political circus: it's an indicator of vulnerabilities in a nation where the far-right holds 30% of the national legislature and has major economic clout.<\/p>\n\n\n\n The alleged deal with BGD Legal, entered into mere days before Simion's April 2025 U.S. visit, purportedly was meant to garner the endorsement of US far-right pundits such as Steve Bannon and activist Jack Posobiek. The company\u2019s connection to George Birnbaum, a strategist with ties to Viktor Orb\u00e1n's anti-globalist election initiatives in Hungary, provides a cross-border character to the scandal. Opponents claim the contract\u2014financed by Romanian state funds allocated to parliamentary groups\u2014is an abuse of public money. AUR refutes the existence of the agreement, stating its<\/a> U.S. costs were negligible and fair.<\/p>\n\n\n\n Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
The surge of far-right political groups in Eastern Europe has been a worrying factor for financiers in the past, but Romania's political intrigue at present could be a breakthrough. Alliance for Romania (AUR) leader George Simion has become the center of a scandal over a contested \u20ac1.5 million lobbying contract with U.S. company BGD Legal and Consulting. <\/p>\n\n\n\n The charges\u2014disavowed by AUR\u2014present troubling inquiries about foreign interference, transparency, and Romania's democratic stability. For investors, this is not just a political circus: it's an indicator of vulnerabilities in a nation where the far-right holds 30% of the national legislature and has major economic clout.<\/p>\n\n\n\n The alleged deal with BGD Legal, entered into mere days before Simion's April 2025 U.S. visit, purportedly was meant to garner the endorsement of US far-right pundits such as Steve Bannon and activist Jack Posobiek. The company\u2019s connection to George Birnbaum, a strategist with ties to Viktor Orb\u00e1n's anti-globalist election initiatives in Hungary, provides a cross-border character to the scandal. Opponents claim the contract\u2014financed by Romanian state funds allocated to parliamentary groups\u2014is an abuse of public money. AUR refutes the existence of the agreement, stating its<\/a> U.S. costs were negligible and fair.<\/p>\n\n\n\n Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
PhRMA has recently conducted high-profile ad campaigns and lobbying efforts to drive reforms against PBMs, who they characterize as \"middlemen\" that cause drug prices to be too high. The efforts are designed to get more savings<\/a> to patients and provide more transparency in the supply chain of drugs. PhRMA spent about $31.7 million in federal lobbying during 2024, ranking among the highest spending of all industries. The group hires several lobbying firms on a regular basis and employs large resources to shape legislation and regulation.<\/p>\n","post_title":"AstraZeneca rejoins major US pharmaceutical lobby after two years away","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"astrazeneca-rejoins-major-us-pharmaceutical-lobby-after-two-years-away","to_ping":"","pinged":"","post_modified":"2025-04-26 20:06:48","post_modified_gmt":"2025-04-26 20:06:48","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7624","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7610,"post_author":"7","post_date":"2025-04-25 18:31:16","post_date_gmt":"2025-04-25 18:31:16","post_content":"\n The surge of far-right political groups in Eastern Europe has been a worrying factor for financiers in the past, but Romania's political intrigue at present could be a breakthrough. Alliance for Romania (AUR) leader George Simion has become the center of a scandal over a contested \u20ac1.5 million lobbying contract with U.S. company BGD Legal and Consulting. <\/p>\n\n\n\n The charges\u2014disavowed by AUR\u2014present troubling inquiries about foreign interference, transparency, and Romania's democratic stability. For investors, this is not just a political circus: it's an indicator of vulnerabilities in a nation where the far-right holds 30% of the national legislature and has major economic clout.<\/p>\n\n\n\n The alleged deal with BGD Legal, entered into mere days before Simion's April 2025 U.S. visit, purportedly was meant to garner the endorsement of US far-right pundits such as Steve Bannon and activist Jack Posobiek. The company\u2019s connection to George Birnbaum, a strategist with ties to Viktor Orb\u00e1n's anti-globalist election initiatives in Hungary, provides a cross-border character to the scandal. Opponents claim the contract\u2014financed by Romanian state funds allocated to parliamentary groups\u2014is an abuse of public money. AUR refutes the existence of the agreement, stating its<\/a> U.S. costs were negligible and fair.<\/p>\n\n\n\n Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
PhRMA also justifies robust patent protections and has resisted global attempts to waive intellectual property rights, including during the COVID-19 pandemic, on the grounds that waivers would destroy innovation and global health responses.<\/p>\n\n\n\n PhRMA has recently conducted high-profile ad campaigns and lobbying efforts to drive reforms against PBMs, who they characterize as \"middlemen\" that cause drug prices to be too high. The efforts are designed to get more savings<\/a> to patients and provide more transparency in the supply chain of drugs. PhRMA spent about $31.7 million in federal lobbying during 2024, ranking among the highest spending of all industries. The group hires several lobbying firms on a regular basis and employs large resources to shape legislation and regulation.<\/p>\n","post_title":"AstraZeneca rejoins major US pharmaceutical lobby after two years away","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"astrazeneca-rejoins-major-us-pharmaceutical-lobby-after-two-years-away","to_ping":"","pinged":"","post_modified":"2025-04-26 20:06:48","post_modified_gmt":"2025-04-26 20:06:48","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7624","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7610,"post_author":"7","post_date":"2025-04-25 18:31:16","post_date_gmt":"2025-04-25 18:31:16","post_content":"\n The surge of far-right political groups in Eastern Europe has been a worrying factor for financiers in the past, but Romania's political intrigue at present could be a breakthrough. Alliance for Romania (AUR) leader George Simion has become the center of a scandal over a contested \u20ac1.5 million lobbying contract with U.S. company BGD Legal and Consulting. <\/p>\n\n\n\n The charges\u2014disavowed by AUR\u2014present troubling inquiries about foreign interference, transparency, and Romania's democratic stability. For investors, this is not just a political circus: it's an indicator of vulnerabilities in a nation where the far-right holds 30% of the national legislature and has major economic clout.<\/p>\n\n\n\n The alleged deal with BGD Legal, entered into mere days before Simion's April 2025 U.S. visit, purportedly was meant to garner the endorsement of US far-right pundits such as Steve Bannon and activist Jack Posobiek. The company\u2019s connection to George Birnbaum, a strategist with ties to Viktor Orb\u00e1n's anti-globalist election initiatives in Hungary, provides a cross-border character to the scandal. Opponents claim the contract\u2014financed by Romanian state funds allocated to parliamentary groups\u2014is an abuse of public money. AUR refutes the existence of the agreement, stating its<\/a> U.S. costs were negligible and fair.<\/p>\n\n\n\n Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
PhRMA has persistently lobbied against federal and state initiatives to set drug price caps, enhance price transparency, or permit Medicare to negotiate prices. PhRMA contends that price controls would suppress innovation and lower the incentive for research and development, although critics point out that drug companies spend more on marketing than on research. <\/p>\n\n\n\n PhRMA also justifies robust patent protections and has resisted global attempts to waive intellectual property rights, including during the COVID-19 pandemic, on the grounds that waivers would destroy innovation and global health responses.<\/p>\n\n\n\n PhRMA has recently conducted high-profile ad campaigns and lobbying efforts to drive reforms against PBMs, who they characterize as \"middlemen\" that cause drug prices to be too high. The efforts are designed to get more savings<\/a> to patients and provide more transparency in the supply chain of drugs. PhRMA spent about $31.7 million in federal lobbying during 2024, ranking among the highest spending of all industries. The group hires several lobbying firms on a regular basis and employs large resources to shape legislation and regulation.<\/p>\n","post_title":"AstraZeneca rejoins major US pharmaceutical lobby after two years away","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"astrazeneca-rejoins-major-us-pharmaceutical-lobby-after-two-years-away","to_ping":"","pinged":"","post_modified":"2025-04-26 20:06:48","post_modified_gmt":"2025-04-26 20:06:48","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7624","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7610,"post_author":"7","post_date":"2025-04-25 18:31:16","post_date_gmt":"2025-04-25 18:31:16","post_content":"\n The surge of far-right political groups in Eastern Europe has been a worrying factor for financiers in the past, but Romania's political intrigue at present could be a breakthrough. Alliance for Romania (AUR) leader George Simion has become the center of a scandal over a contested \u20ac1.5 million lobbying contract with U.S. company BGD Legal and Consulting. <\/p>\n\n\n\n The charges\u2014disavowed by AUR\u2014present troubling inquiries about foreign interference, transparency, and Romania's democratic stability. For investors, this is not just a political circus: it's an indicator of vulnerabilities in a nation where the far-right holds 30% of the national legislature and has major economic clout.<\/p>\n\n\n\n The alleged deal with BGD Legal, entered into mere days before Simion's April 2025 U.S. visit, purportedly was meant to garner the endorsement of US far-right pundits such as Steve Bannon and activist Jack Posobiek. The company\u2019s connection to George Birnbaum, a strategist with ties to Viktor Orb\u00e1n's anti-globalist election initiatives in Hungary, provides a cross-border character to the scandal. Opponents claim the contract\u2014financed by Romanian state funds allocated to parliamentary groups\u2014is an abuse of public money. AUR refutes the existence of the agreement, stating its<\/a> U.S. costs were negligible and fair.<\/p>\n\n\n\n Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
The Pharmaceutical Research and Manufacturers of America (PhRMA) is the country's largest trade association of major drug manufacturers, based in Washington, D.C. Founded in 1958, PhRMA has been one of the most powerful lobbying groups in the nation, working on behalf of the pharmaceutical sector across a broad spectrum of policy matters.<\/p>\n\n\n\n PhRMA has persistently lobbied against federal and state initiatives to set drug price caps, enhance price transparency, or permit Medicare to negotiate prices. PhRMA contends that price controls would suppress innovation and lower the incentive for research and development, although critics point out that drug companies spend more on marketing than on research. <\/p>\n\n\n\n PhRMA also justifies robust patent protections and has resisted global attempts to waive intellectual property rights, including during the COVID-19 pandemic, on the grounds that waivers would destroy innovation and global health responses.<\/p>\n\n\n\n PhRMA has recently conducted high-profile ad campaigns and lobbying efforts to drive reforms against PBMs, who they characterize as \"middlemen\" that cause drug prices to be too high. The efforts are designed to get more savings<\/a> to patients and provide more transparency in the supply chain of drugs. PhRMA spent about $31.7 million in federal lobbying during 2024, ranking among the highest spending of all industries. The group hires several lobbying firms on a regular basis and employs large resources to shape legislation and regulation.<\/p>\n","post_title":"AstraZeneca rejoins major US pharmaceutical lobby after two years away","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"astrazeneca-rejoins-major-us-pharmaceutical-lobby-after-two-years-away","to_ping":"","pinged":"","post_modified":"2025-04-26 20:06:48","post_modified_gmt":"2025-04-26 20:06:48","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7624","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7610,"post_author":"7","post_date":"2025-04-25 18:31:16","post_date_gmt":"2025-04-25 18:31:16","post_content":"\n The surge of far-right political groups in Eastern Europe has been a worrying factor for financiers in the past, but Romania's political intrigue at present could be a breakthrough. Alliance for Romania (AUR) leader George Simion has become the center of a scandal over a contested \u20ac1.5 million lobbying contract with U.S. company BGD Legal and Consulting. <\/p>\n\n\n\n The charges\u2014disavowed by AUR\u2014present troubling inquiries about foreign interference, transparency, and Romania's democratic stability. For investors, this is not just a political circus: it's an indicator of vulnerabilities in a nation where the far-right holds 30% of the national legislature and has major economic clout.<\/p>\n\n\n\n The alleged deal with BGD Legal, entered into mere days before Simion's April 2025 U.S. visit, purportedly was meant to garner the endorsement of US far-right pundits such as Steve Bannon and activist Jack Posobiek. The company\u2019s connection to George Birnbaum, a strategist with ties to Viktor Orb\u00e1n's anti-globalist election initiatives in Hungary, provides a cross-border character to the scandal. Opponents claim the contract\u2014financed by Romanian state funds allocated to parliamentary groups\u2014is an abuse of public money. AUR refutes the existence of the agreement, stating its<\/a> U.S. costs were negligible and fair.<\/p>\n\n\n\n Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
Soriot stated that AstraZeneca is \"committed to collaborating with PhRMA and policymakers to maintain the U.S. as a global authority in biomedical innovation while ensuring that medicines are affordable for all who need them.\" In May 2023, the London-based company chose to exit the group and pursue different advocacy strategies at both state and federal levels.<\/p>\n\n\n\n The Pharmaceutical Research and Manufacturers of America (PhRMA) is the country's largest trade association of major drug manufacturers, based in Washington, D.C. Founded in 1958, PhRMA has been one of the most powerful lobbying groups in the nation, working on behalf of the pharmaceutical sector across a broad spectrum of policy matters.<\/p>\n\n\n\n PhRMA has persistently lobbied against federal and state initiatives to set drug price caps, enhance price transparency, or permit Medicare to negotiate prices. PhRMA contends that price controls would suppress innovation and lower the incentive for research and development, although critics point out that drug companies spend more on marketing than on research. <\/p>\n\n\n\n PhRMA also justifies robust patent protections and has resisted global attempts to waive intellectual property rights, including during the COVID-19 pandemic, on the grounds that waivers would destroy innovation and global health responses.<\/p>\n\n\n\n PhRMA has recently conducted high-profile ad campaigns and lobbying efforts to drive reforms against PBMs, who they characterize as \"middlemen\" that cause drug prices to be too high. The efforts are designed to get more savings<\/a> to patients and provide more transparency in the supply chain of drugs. PhRMA spent about $31.7 million in federal lobbying during 2024, ranking among the highest spending of all industries. The group hires several lobbying firms on a regular basis and employs large resources to shape legislation and regulation.<\/p>\n","post_title":"AstraZeneca rejoins major US pharmaceutical lobby after two years away","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"astrazeneca-rejoins-major-us-pharmaceutical-lobby-after-two-years-away","to_ping":"","pinged":"","post_modified":"2025-04-26 20:06:48","post_modified_gmt":"2025-04-26 20:06:48","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7624","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7610,"post_author":"7","post_date":"2025-04-25 18:31:16","post_date_gmt":"2025-04-25 18:31:16","post_content":"\n The surge of far-right political groups in Eastern Europe has been a worrying factor for financiers in the past, but Romania's political intrigue at present could be a breakthrough. Alliance for Romania (AUR) leader George Simion has become the center of a scandal over a contested \u20ac1.5 million lobbying contract with U.S. company BGD Legal and Consulting. <\/p>\n\n\n\n The charges\u2014disavowed by AUR\u2014present troubling inquiries about foreign interference, transparency, and Romania's democratic stability. For investors, this is not just a political circus: it's an indicator of vulnerabilities in a nation where the far-right holds 30% of the national legislature and has major economic clout.<\/p>\n\n\n\n The alleged deal with BGD Legal, entered into mere days before Simion's April 2025 U.S. visit, purportedly was meant to garner the endorsement of US far-right pundits such as Steve Bannon and activist Jack Posobiek. The company\u2019s connection to George Birnbaum, a strategist with ties to Viktor Orb\u00e1n's anti-globalist election initiatives in Hungary, provides a cross-border character to the scandal. Opponents claim the contract\u2014financed by Romanian state funds allocated to parliamentary groups\u2014is an abuse of public money. AUR refutes the existence of the agreement, stating its<\/a> U.S. costs were negligible and fair.<\/p>\n\n\n\n Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
\"We are also expanding our presence in the United States with significant investments in research, development and manufacturing,\" said Pascal Soriot, AstraZeneca\u2019s Chief Executive Officer.<\/p>\n\n\n\n Soriot stated that AstraZeneca is \"committed to collaborating with PhRMA and policymakers to maintain the U.S. as a global authority in biomedical innovation while ensuring that medicines are affordable for all who need them.\" In May 2023, the London-based company chose to exit the group and pursue different advocacy strategies at both state and federal levels.<\/p>\n\n\n\n The Pharmaceutical Research and Manufacturers of America (PhRMA) is the country's largest trade association of major drug manufacturers, based in Washington, D.C. Founded in 1958, PhRMA has been one of the most powerful lobbying groups in the nation, working on behalf of the pharmaceutical sector across a broad spectrum of policy matters.<\/p>\n\n\n\n PhRMA has persistently lobbied against federal and state initiatives to set drug price caps, enhance price transparency, or permit Medicare to negotiate prices. PhRMA contends that price controls would suppress innovation and lower the incentive for research and development, although critics point out that drug companies spend more on marketing than on research. <\/p>\n\n\n\n PhRMA also justifies robust patent protections and has resisted global attempts to waive intellectual property rights, including during the COVID-19 pandemic, on the grounds that waivers would destroy innovation and global health responses.<\/p>\n\n\n\n PhRMA has recently conducted high-profile ad campaigns and lobbying efforts to drive reforms against PBMs, who they characterize as \"middlemen\" that cause drug prices to be too high. The efforts are designed to get more savings<\/a> to patients and provide more transparency in the supply chain of drugs. PhRMA spent about $31.7 million in federal lobbying during 2024, ranking among the highest spending of all industries. The group hires several lobbying firms on a regular basis and employs large resources to shape legislation and regulation.<\/p>\n","post_title":"AstraZeneca rejoins major US pharmaceutical lobby after two years away","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"astrazeneca-rejoins-major-us-pharmaceutical-lobby-after-two-years-away","to_ping":"","pinged":"","post_modified":"2025-04-26 20:06:48","post_modified_gmt":"2025-04-26 20:06:48","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7624","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7610,"post_author":"7","post_date":"2025-04-25 18:31:16","post_date_gmt":"2025-04-25 18:31:16","post_content":"\n The surge of far-right political groups in Eastern Europe has been a worrying factor for financiers in the past, but Romania's political intrigue at present could be a breakthrough. Alliance for Romania (AUR) leader George Simion has become the center of a scandal over a contested \u20ac1.5 million lobbying contract with U.S. company BGD Legal and Consulting. <\/p>\n\n\n\n The charges\u2014disavowed by AUR\u2014present troubling inquiries about foreign interference, transparency, and Romania's democratic stability. For investors, this is not just a political circus: it's an indicator of vulnerabilities in a nation where the far-right holds 30% of the national legislature and has major economic clout.<\/p>\n\n\n\n The alleged deal with BGD Legal, entered into mere days before Simion's April 2025 U.S. visit, purportedly was meant to garner the endorsement of US far-right pundits such as Steve Bannon and activist Jack Posobiek. The company\u2019s connection to George Birnbaum, a strategist with ties to Viktor Orb\u00e1n's anti-globalist election initiatives in Hungary, provides a cross-border character to the scandal. Opponents claim the contract\u2014financed by Romanian state funds allocated to parliamentary groups\u2014is an abuse of public money. AUR refutes the existence of the agreement, stating its<\/a> U.S. costs were negligible and fair.<\/p>\n\n\n\n Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
The company re-engages with the trade organization as pharmaceutical firms get ready to tackle possible tariffs and drug import fees during President Donald Trump's administration<\/a>.<\/p>\n\n\n\n \"We are also expanding our presence in the United States with significant investments in research, development and manufacturing,\" said Pascal Soriot, AstraZeneca\u2019s Chief Executive Officer.<\/p>\n\n\n\n Soriot stated that AstraZeneca is \"committed to collaborating with PhRMA and policymakers to maintain the U.S. as a global authority in biomedical innovation while ensuring that medicines are affordable for all who need them.\" In May 2023, the London-based company chose to exit the group and pursue different advocacy strategies at both state and federal levels.<\/p>\n\n\n\n The Pharmaceutical Research and Manufacturers of America (PhRMA) is the country's largest trade association of major drug manufacturers, based in Washington, D.C. Founded in 1958, PhRMA has been one of the most powerful lobbying groups in the nation, working on behalf of the pharmaceutical sector across a broad spectrum of policy matters.<\/p>\n\n\n\n PhRMA has persistently lobbied against federal and state initiatives to set drug price caps, enhance price transparency, or permit Medicare to negotiate prices. PhRMA contends that price controls would suppress innovation and lower the incentive for research and development, although critics point out that drug companies spend more on marketing than on research. <\/p>\n\n\n\n PhRMA also justifies robust patent protections and has resisted global attempts to waive intellectual property rights, including during the COVID-19 pandemic, on the grounds that waivers would destroy innovation and global health responses.<\/p>\n\n\n\n PhRMA has recently conducted high-profile ad campaigns and lobbying efforts to drive reforms against PBMs, who they characterize as \"middlemen\" that cause drug prices to be too high. The efforts are designed to get more savings<\/a> to patients and provide more transparency in the supply chain of drugs. PhRMA spent about $31.7 million in federal lobbying during 2024, ranking among the highest spending of all industries. The group hires several lobbying firms on a regular basis and employs large resources to shape legislation and regulation.<\/p>\n","post_title":"AstraZeneca rejoins major US pharmaceutical lobby after two years away","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"astrazeneca-rejoins-major-us-pharmaceutical-lobby-after-two-years-away","to_ping":"","pinged":"","post_modified":"2025-04-26 20:06:48","post_modified_gmt":"2025-04-26 20:06:48","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7624","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7610,"post_author":"7","post_date":"2025-04-25 18:31:16","post_date_gmt":"2025-04-25 18:31:16","post_content":"\n The surge of far-right political groups in Eastern Europe has been a worrying factor for financiers in the past, but Romania's political intrigue at present could be a breakthrough. Alliance for Romania (AUR) leader George Simion has become the center of a scandal over a contested \u20ac1.5 million lobbying contract with U.S. company BGD Legal and Consulting. <\/p>\n\n\n\n The charges\u2014disavowed by AUR\u2014present troubling inquiries about foreign interference, transparency, and Romania's democratic stability. For investors, this is not just a political circus: it's an indicator of vulnerabilities in a nation where the far-right holds 30% of the national legislature and has major economic clout.<\/p>\n\n\n\n The alleged deal with BGD Legal, entered into mere days before Simion's April 2025 U.S. visit, purportedly was meant to garner the endorsement of US far-right pundits such as Steve Bannon and activist Jack Posobiek. The company\u2019s connection to George Birnbaum, a strategist with ties to Viktor Orb\u00e1n's anti-globalist election initiatives in Hungary, provides a cross-border character to the scandal. Opponents claim the contract\u2014financed by Romanian state funds allocated to parliamentary groups\u2014is an abuse of public money. AUR refutes the existence of the agreement, stating its<\/a> U.S. costs were negligible and fair.<\/p>\n\n\n\n Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
AstraZeneca has reentered the primary U.S. pharmaceutical lobby group nearly two years after its exit, according to the Pharmaceutical Research and Manufacturers of America (PhRMA). This move comes after the British drugmaker declared a $3.5 billion acquisition in the United States last year, intended to enhance its research and development (R&D) and product development abilities by the end of 2026.<\/p>\n\n\n\n The company re-engages with the trade organization as pharmaceutical firms get ready to tackle possible tariffs and drug import fees during President Donald Trump's administration<\/a>.<\/p>\n\n\n\n \"We are also expanding our presence in the United States with significant investments in research, development and manufacturing,\" said Pascal Soriot, AstraZeneca\u2019s Chief Executive Officer.<\/p>\n\n\n\n Soriot stated that AstraZeneca is \"committed to collaborating with PhRMA and policymakers to maintain the U.S. as a global authority in biomedical innovation while ensuring that medicines are affordable for all who need them.\" In May 2023, the London-based company chose to exit the group and pursue different advocacy strategies at both state and federal levels.<\/p>\n\n\n\n The Pharmaceutical Research and Manufacturers of America (PhRMA) is the country's largest trade association of major drug manufacturers, based in Washington, D.C. Founded in 1958, PhRMA has been one of the most powerful lobbying groups in the nation, working on behalf of the pharmaceutical sector across a broad spectrum of policy matters.<\/p>\n\n\n\n PhRMA has persistently lobbied against federal and state initiatives to set drug price caps, enhance price transparency, or permit Medicare to negotiate prices. PhRMA contends that price controls would suppress innovation and lower the incentive for research and development, although critics point out that drug companies spend more on marketing than on research. <\/p>\n\n\n\n PhRMA also justifies robust patent protections and has resisted global attempts to waive intellectual property rights, including during the COVID-19 pandemic, on the grounds that waivers would destroy innovation and global health responses.<\/p>\n\n\n\n PhRMA has recently conducted high-profile ad campaigns and lobbying efforts to drive reforms against PBMs, who they characterize as \"middlemen\" that cause drug prices to be too high. The efforts are designed to get more savings<\/a> to patients and provide more transparency in the supply chain of drugs. PhRMA spent about $31.7 million in federal lobbying during 2024, ranking among the highest spending of all industries. The group hires several lobbying firms on a regular basis and employs large resources to shape legislation and regulation.<\/p>\n","post_title":"AstraZeneca rejoins major US pharmaceutical lobby after two years away","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"astrazeneca-rejoins-major-us-pharmaceutical-lobby-after-two-years-away","to_ping":"","pinged":"","post_modified":"2025-04-26 20:06:48","post_modified_gmt":"2025-04-26 20:06:48","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7624","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7610,"post_author":"7","post_date":"2025-04-25 18:31:16","post_date_gmt":"2025-04-25 18:31:16","post_content":"\n The surge of far-right political groups in Eastern Europe has been a worrying factor for financiers in the past, but Romania's political intrigue at present could be a breakthrough. Alliance for Romania (AUR) leader George Simion has become the center of a scandal over a contested \u20ac1.5 million lobbying contract with U.S. company BGD Legal and Consulting. <\/p>\n\n\n\n The charges\u2014disavowed by AUR\u2014present troubling inquiries about foreign interference, transparency, and Romania's democratic stability. For investors, this is not just a political circus: it's an indicator of vulnerabilities in a nation where the far-right holds 30% of the national legislature and has major economic clout.<\/p>\n\n\n\n The alleged deal with BGD Legal, entered into mere days before Simion's April 2025 U.S. visit, purportedly was meant to garner the endorsement of US far-right pundits such as Steve Bannon and activist Jack Posobiek. The company\u2019s connection to George Birnbaum, a strategist with ties to Viktor Orb\u00e1n's anti-globalist election initiatives in Hungary, provides a cross-border character to the scandal. Opponents claim the contract\u2014financed by Romanian state funds allocated to parliamentary groups\u2014is an abuse of public money. AUR refutes the existence of the agreement, stating its<\/a> U.S. costs were negligible and fair.<\/p>\n\n\n\n Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
The recommendations aim to address a regulatory process at the SEC described in the report as \u201cinconsistent, opaque, and unpredictable.\u201d Additionally, it focuses on unaccountable proxy advisory companies that<\/a> significantly influence vote outcomes and corporate governance. BRT emphasized the need for broader structural reforms to shield investors and to ensure that US capital markets remain a catalyst for economic growth and opportunity.\u00a0<\/p>\n","post_title":"US lobby group calls for reform of outdated proxy voting systems","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"us-lobby-group-calls-for-reform-of-outdated-proxy-voting-systems","to_ping":"","pinged":"","post_modified":"2025-04-26 19:58:17","post_modified_gmt":"2025-04-26 19:58:17","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7623","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7624,"post_author":"7","post_date":"2025-04-26 19:55:57","post_date_gmt":"2025-04-26 19:55:57","post_content":"\n AstraZeneca has reentered the primary U.S. pharmaceutical lobby group nearly two years after its exit, according to the Pharmaceutical Research and Manufacturers of America (PhRMA). This move comes after the British drugmaker declared a $3.5 billion acquisition in the United States last year, intended to enhance its research and development (R&D) and product development abilities by the end of 2026.<\/p>\n\n\n\n The company re-engages with the trade organization as pharmaceutical firms get ready to tackle possible tariffs and drug import fees during President Donald Trump's administration<\/a>.<\/p>\n\n\n\n \"We are also expanding our presence in the United States with significant investments in research, development and manufacturing,\" said Pascal Soriot, AstraZeneca\u2019s Chief Executive Officer.<\/p>\n\n\n\n Soriot stated that AstraZeneca is \"committed to collaborating with PhRMA and policymakers to maintain the U.S. as a global authority in biomedical innovation while ensuring that medicines are affordable for all who need them.\" In May 2023, the London-based company chose to exit the group and pursue different advocacy strategies at both state and federal levels.<\/p>\n\n\n\n The Pharmaceutical Research and Manufacturers of America (PhRMA) is the country's largest trade association of major drug manufacturers, based in Washington, D.C. Founded in 1958, PhRMA has been one of the most powerful lobbying groups in the nation, working on behalf of the pharmaceutical sector across a broad spectrum of policy matters.<\/p>\n\n\n\n PhRMA has persistently lobbied against federal and state initiatives to set drug price caps, enhance price transparency, or permit Medicare to negotiate prices. PhRMA contends that price controls would suppress innovation and lower the incentive for research and development, although critics point out that drug companies spend more on marketing than on research. <\/p>\n\n\n\n PhRMA also justifies robust patent protections and has resisted global attempts to waive intellectual property rights, including during the COVID-19 pandemic, on the grounds that waivers would destroy innovation and global health responses.<\/p>\n\n\n\n PhRMA has recently conducted high-profile ad campaigns and lobbying efforts to drive reforms against PBMs, who they characterize as \"middlemen\" that cause drug prices to be too high. The efforts are designed to get more savings<\/a> to patients and provide more transparency in the supply chain of drugs. PhRMA spent about $31.7 million in federal lobbying during 2024, ranking among the highest spending of all industries. The group hires several lobbying firms on a regular basis and employs large resources to shape legislation and regulation.<\/p>\n","post_title":"AstraZeneca rejoins major US pharmaceutical lobby after two years away","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"astrazeneca-rejoins-major-us-pharmaceutical-lobby-after-two-years-away","to_ping":"","pinged":"","post_modified":"2025-04-26 20:06:48","post_modified_gmt":"2025-04-26 20:06:48","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7624","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7610,"post_author":"7","post_date":"2025-04-25 18:31:16","post_date_gmt":"2025-04-25 18:31:16","post_content":"\n The surge of far-right political groups in Eastern Europe has been a worrying factor for financiers in the past, but Romania's political intrigue at present could be a breakthrough. Alliance for Romania (AUR) leader George Simion has become the center of a scandal over a contested \u20ac1.5 million lobbying contract with U.S. company BGD Legal and Consulting. <\/p>\n\n\n\n The charges\u2014disavowed by AUR\u2014present troubling inquiries about foreign interference, transparency, and Romania's democratic stability. For investors, this is not just a political circus: it's an indicator of vulnerabilities in a nation where the far-right holds 30% of the national legislature and has major economic clout.<\/p>\n\n\n\n The alleged deal with BGD Legal, entered into mere days before Simion's April 2025 U.S. visit, purportedly was meant to garner the endorsement of US far-right pundits such as Steve Bannon and activist Jack Posobiek. The company\u2019s connection to George Birnbaum, a strategist with ties to Viktor Orb\u00e1n's anti-globalist election initiatives in Hungary, provides a cross-border character to the scandal. Opponents claim the contract\u2014financed by Romanian state funds allocated to parliamentary groups\u2014is an abuse of public money. AUR refutes the existence of the agreement, stating its<\/a> U.S. costs were negligible and fair.<\/p>\n\n\n\n Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
The recommendations aim to address a regulatory process at the SEC described in the report as \u201cinconsistent, opaque, and unpredictable.\u201d Additionally, it focuses on unaccountable proxy advisory companies that<\/a> significantly influence vote outcomes and corporate governance. BRT emphasized the need for broader structural reforms to shield investors and to ensure that US capital markets remain a catalyst for economic growth and opportunity.\u00a0<\/p>\n","post_title":"US lobby group calls for reform of outdated proxy voting systems","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"us-lobby-group-calls-for-reform-of-outdated-proxy-voting-systems","to_ping":"","pinged":"","post_modified":"2025-04-26 19:58:17","post_modified_gmt":"2025-04-26 19:58:17","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7623","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7624,"post_author":"7","post_date":"2025-04-26 19:55:57","post_date_gmt":"2025-04-26 19:55:57","post_content":"\n AstraZeneca has reentered the primary U.S. pharmaceutical lobby group nearly two years after its exit, according to the Pharmaceutical Research and Manufacturers of America (PhRMA). This move comes after the British drugmaker declared a $3.5 billion acquisition in the United States last year, intended to enhance its research and development (R&D) and product development abilities by the end of 2026.<\/p>\n\n\n\n The company re-engages with the trade organization as pharmaceutical firms get ready to tackle possible tariffs and drug import fees during President Donald Trump's administration<\/a>.<\/p>\n\n\n\n \"We are also expanding our presence in the United States with significant investments in research, development and manufacturing,\" said Pascal Soriot, AstraZeneca\u2019s Chief Executive Officer.<\/p>\n\n\n\n Soriot stated that AstraZeneca is \"committed to collaborating with PhRMA and policymakers to maintain the U.S. as a global authority in biomedical innovation while ensuring that medicines are affordable for all who need them.\" In May 2023, the London-based company chose to exit the group and pursue different advocacy strategies at both state and federal levels.<\/p>\n\n\n\n The Pharmaceutical Research and Manufacturers of America (PhRMA) is the country's largest trade association of major drug manufacturers, based in Washington, D.C. Founded in 1958, PhRMA has been one of the most powerful lobbying groups in the nation, working on behalf of the pharmaceutical sector across a broad spectrum of policy matters.<\/p>\n\n\n\n PhRMA has persistently lobbied against federal and state initiatives to set drug price caps, enhance price transparency, or permit Medicare to negotiate prices. PhRMA contends that price controls would suppress innovation and lower the incentive for research and development, although critics point out that drug companies spend more on marketing than on research. <\/p>\n\n\n\n PhRMA also justifies robust patent protections and has resisted global attempts to waive intellectual property rights, including during the COVID-19 pandemic, on the grounds that waivers would destroy innovation and global health responses.<\/p>\n\n\n\n PhRMA has recently conducted high-profile ad campaigns and lobbying efforts to drive reforms against PBMs, who they characterize as \"middlemen\" that cause drug prices to be too high. The efforts are designed to get more savings<\/a> to patients and provide more transparency in the supply chain of drugs. PhRMA spent about $31.7 million in federal lobbying during 2024, ranking among the highest spending of all industries. The group hires several lobbying firms on a regular basis and employs large resources to shape legislation and regulation.<\/p>\n","post_title":"AstraZeneca rejoins major US pharmaceutical lobby after two years away","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"astrazeneca-rejoins-major-us-pharmaceutical-lobby-after-two-years-away","to_ping":"","pinged":"","post_modified":"2025-04-26 20:06:48","post_modified_gmt":"2025-04-26 20:06:48","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7624","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7610,"post_author":"7","post_date":"2025-04-25 18:31:16","post_date_gmt":"2025-04-25 18:31:16","post_content":"\n The surge of far-right political groups in Eastern Europe has been a worrying factor for financiers in the past, but Romania's political intrigue at present could be a breakthrough. Alliance for Romania (AUR) leader George Simion has become the center of a scandal over a contested \u20ac1.5 million lobbying contract with U.S. company BGD Legal and Consulting. <\/p>\n\n\n\n The charges\u2014disavowed by AUR\u2014present troubling inquiries about foreign interference, transparency, and Romania's democratic stability. For investors, this is not just a political circus: it's an indicator of vulnerabilities in a nation where the far-right holds 30% of the national legislature and has major economic clout.<\/p>\n\n\n\n The alleged deal with BGD Legal, entered into mere days before Simion's April 2025 U.S. visit, purportedly was meant to garner the endorsement of US far-right pundits such as Steve Bannon and activist Jack Posobiek. The company\u2019s connection to George Birnbaum, a strategist with ties to Viktor Orb\u00e1n's anti-globalist election initiatives in Hungary, provides a cross-border character to the scandal. Opponents claim the contract\u2014financed by Romanian state funds allocated to parliamentary groups\u2014is an abuse of public money. AUR refutes the existence of the agreement, stating its<\/a> U.S. costs were negligible and fair.<\/p>\n\n\n\n Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
The recommendations aim to address a regulatory process at the SEC described in the report as \u201cinconsistent, opaque, and unpredictable.\u201d Additionally, it focuses on unaccountable proxy advisory companies that<\/a> significantly influence vote outcomes and corporate governance. BRT emphasized the need for broader structural reforms to shield investors and to ensure that US capital markets remain a catalyst for economic growth and opportunity.\u00a0<\/p>\n","post_title":"US lobby group calls for reform of outdated proxy voting systems","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"us-lobby-group-calls-for-reform-of-outdated-proxy-voting-systems","to_ping":"","pinged":"","post_modified":"2025-04-26 19:58:17","post_modified_gmt":"2025-04-26 19:58:17","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7623","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7624,"post_author":"7","post_date":"2025-04-26 19:55:57","post_date_gmt":"2025-04-26 19:55:57","post_content":"\n AstraZeneca has reentered the primary U.S. pharmaceutical lobby group nearly two years after its exit, according to the Pharmaceutical Research and Manufacturers of America (PhRMA). This move comes after the British drugmaker declared a $3.5 billion acquisition in the United States last year, intended to enhance its research and development (R&D) and product development abilities by the end of 2026.<\/p>\n\n\n\n The company re-engages with the trade organization as pharmaceutical firms get ready to tackle possible tariffs and drug import fees during President Donald Trump's administration<\/a>.<\/p>\n\n\n\n \"We are also expanding our presence in the United States with significant investments in research, development and manufacturing,\" said Pascal Soriot, AstraZeneca\u2019s Chief Executive Officer.<\/p>\n\n\n\n Soriot stated that AstraZeneca is \"committed to collaborating with PhRMA and policymakers to maintain the U.S. as a global authority in biomedical innovation while ensuring that medicines are affordable for all who need them.\" In May 2023, the London-based company chose to exit the group and pursue different advocacy strategies at both state and federal levels.<\/p>\n\n\n\n The Pharmaceutical Research and Manufacturers of America (PhRMA) is the country's largest trade association of major drug manufacturers, based in Washington, D.C. Founded in 1958, PhRMA has been one of the most powerful lobbying groups in the nation, working on behalf of the pharmaceutical sector across a broad spectrum of policy matters.<\/p>\n\n\n\n PhRMA has persistently lobbied against federal and state initiatives to set drug price caps, enhance price transparency, or permit Medicare to negotiate prices. PhRMA contends that price controls would suppress innovation and lower the incentive for research and development, although critics point out that drug companies spend more on marketing than on research. <\/p>\n\n\n\n PhRMA also justifies robust patent protections and has resisted global attempts to waive intellectual property rights, including during the COVID-19 pandemic, on the grounds that waivers would destroy innovation and global health responses.<\/p>\n\n\n\n PhRMA has recently conducted high-profile ad campaigns and lobbying efforts to drive reforms against PBMs, who they characterize as \"middlemen\" that cause drug prices to be too high. The efforts are designed to get more savings<\/a> to patients and provide more transparency in the supply chain of drugs. PhRMA spent about $31.7 million in federal lobbying during 2024, ranking among the highest spending of all industries. The group hires several lobbying firms on a regular basis and employs large resources to shape legislation and regulation.<\/p>\n","post_title":"AstraZeneca rejoins major US pharmaceutical lobby after two years away","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"astrazeneca-rejoins-major-us-pharmaceutical-lobby-after-two-years-away","to_ping":"","pinged":"","post_modified":"2025-04-26 20:06:48","post_modified_gmt":"2025-04-26 20:06:48","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7624","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7610,"post_author":"7","post_date":"2025-04-25 18:31:16","post_date_gmt":"2025-04-25 18:31:16","post_content":"\n The surge of far-right political groups in Eastern Europe has been a worrying factor for financiers in the past, but Romania's political intrigue at present could be a breakthrough. Alliance for Romania (AUR) leader George Simion has become the center of a scandal over a contested \u20ac1.5 million lobbying contract with U.S. company BGD Legal and Consulting. <\/p>\n\n\n\n The charges\u2014disavowed by AUR\u2014present troubling inquiries about foreign interference, transparency, and Romania's democratic stability. For investors, this is not just a political circus: it's an indicator of vulnerabilities in a nation where the far-right holds 30% of the national legislature and has major economic clout.<\/p>\n\n\n\n The alleged deal with BGD Legal, entered into mere days before Simion's April 2025 U.S. visit, purportedly was meant to garner the endorsement of US far-right pundits such as Steve Bannon and activist Jack Posobiek. The company\u2019s connection to George Birnbaum, a strategist with ties to Viktor Orb\u00e1n's anti-globalist election initiatives in Hungary, provides a cross-border character to the scandal. Opponents claim the contract\u2014financed by Romanian state funds allocated to parliamentary groups\u2014is an abuse of public money. AUR refutes the existence of the agreement, stating its<\/a> U.S. costs were negligible and fair.<\/p>\n\n\n\n Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
The recommendations aim to address a regulatory process at the SEC described in the report as \u201cinconsistent, opaque, and unpredictable.\u201d Additionally, it focuses on unaccountable proxy advisory companies that<\/a> significantly influence vote outcomes and corporate governance. BRT emphasized the need for broader structural reforms to shield investors and to ensure that US capital markets remain a catalyst for economic growth and opportunity.\u00a0<\/p>\n","post_title":"US lobby group calls for reform of outdated proxy voting systems","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"us-lobby-group-calls-for-reform-of-outdated-proxy-voting-systems","to_ping":"","pinged":"","post_modified":"2025-04-26 19:58:17","post_modified_gmt":"2025-04-26 19:58:17","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7623","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7624,"post_author":"7","post_date":"2025-04-26 19:55:57","post_date_gmt":"2025-04-26 19:55:57","post_content":"\n AstraZeneca has reentered the primary U.S. pharmaceutical lobby group nearly two years after its exit, according to the Pharmaceutical Research and Manufacturers of America (PhRMA). This move comes after the British drugmaker declared a $3.5 billion acquisition in the United States last year, intended to enhance its research and development (R&D) and product development abilities by the end of 2026.<\/p>\n\n\n\n The company re-engages with the trade organization as pharmaceutical firms get ready to tackle possible tariffs and drug import fees during President Donald Trump's administration<\/a>.<\/p>\n\n\n\n \"We are also expanding our presence in the United States with significant investments in research, development and manufacturing,\" said Pascal Soriot, AstraZeneca\u2019s Chief Executive Officer.<\/p>\n\n\n\n Soriot stated that AstraZeneca is \"committed to collaborating with PhRMA and policymakers to maintain the U.S. as a global authority in biomedical innovation while ensuring that medicines are affordable for all who need them.\" In May 2023, the London-based company chose to exit the group and pursue different advocacy strategies at both state and federal levels.<\/p>\n\n\n\n The Pharmaceutical Research and Manufacturers of America (PhRMA) is the country's largest trade association of major drug manufacturers, based in Washington, D.C. Founded in 1958, PhRMA has been one of the most powerful lobbying groups in the nation, working on behalf of the pharmaceutical sector across a broad spectrum of policy matters.<\/p>\n\n\n\n PhRMA has persistently lobbied against federal and state initiatives to set drug price caps, enhance price transparency, or permit Medicare to negotiate prices. PhRMA contends that price controls would suppress innovation and lower the incentive for research and development, although critics point out that drug companies spend more on marketing than on research. <\/p>\n\n\n\n PhRMA also justifies robust patent protections and has resisted global attempts to waive intellectual property rights, including during the COVID-19 pandemic, on the grounds that waivers would destroy innovation and global health responses.<\/p>\n\n\n\n PhRMA has recently conducted high-profile ad campaigns and lobbying efforts to drive reforms against PBMs, who they characterize as \"middlemen\" that cause drug prices to be too high. The efforts are designed to get more savings<\/a> to patients and provide more transparency in the supply chain of drugs. PhRMA spent about $31.7 million in federal lobbying during 2024, ranking among the highest spending of all industries. The group hires several lobbying firms on a regular basis and employs large resources to shape legislation and regulation.<\/p>\n","post_title":"AstraZeneca rejoins major US pharmaceutical lobby after two years away","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"astrazeneca-rejoins-major-us-pharmaceutical-lobby-after-two-years-away","to_ping":"","pinged":"","post_modified":"2025-04-26 20:06:48","post_modified_gmt":"2025-04-26 20:06:48","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7624","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7610,"post_author":"7","post_date":"2025-04-25 18:31:16","post_date_gmt":"2025-04-25 18:31:16","post_content":"\n The surge of far-right political groups in Eastern Europe has been a worrying factor for financiers in the past, but Romania's political intrigue at present could be a breakthrough. Alliance for Romania (AUR) leader George Simion has become the center of a scandal over a contested \u20ac1.5 million lobbying contract with U.S. company BGD Legal and Consulting. <\/p>\n\n\n\n The charges\u2014disavowed by AUR\u2014present troubling inquiries about foreign interference, transparency, and Romania's democratic stability. For investors, this is not just a political circus: it's an indicator of vulnerabilities in a nation where the far-right holds 30% of the national legislature and has major economic clout.<\/p>\n\n\n\n The alleged deal with BGD Legal, entered into mere days before Simion's April 2025 U.S. visit, purportedly was meant to garner the endorsement of US far-right pundits such as Steve Bannon and activist Jack Posobiek. The company\u2019s connection to George Birnbaum, a strategist with ties to Viktor Orb\u00e1n's anti-globalist election initiatives in Hungary, provides a cross-border character to the scandal. Opponents claim the contract\u2014financed by Romanian state funds allocated to parliamentary groups\u2014is an abuse of public money. AUR refutes the existence of the agreement, stating its<\/a> U.S. costs were negligible and fair.<\/p>\n\n\n\n Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
The recommendations aim to address a regulatory process at the SEC described in the report as \u201cinconsistent, opaque, and unpredictable.\u201d Additionally, it focuses on unaccountable proxy advisory companies that<\/a> significantly influence vote outcomes and corporate governance. BRT emphasized the need for broader structural reforms to shield investors and to ensure that US capital markets remain a catalyst for economic growth and opportunity.\u00a0<\/p>\n","post_title":"US lobby group calls for reform of outdated proxy voting systems","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"us-lobby-group-calls-for-reform-of-outdated-proxy-voting-systems","to_ping":"","pinged":"","post_modified":"2025-04-26 19:58:17","post_modified_gmt":"2025-04-26 19:58:17","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7623","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7624,"post_author":"7","post_date":"2025-04-26 19:55:57","post_date_gmt":"2025-04-26 19:55:57","post_content":"\n AstraZeneca has reentered the primary U.S. pharmaceutical lobby group nearly two years after its exit, according to the Pharmaceutical Research and Manufacturers of America (PhRMA). This move comes after the British drugmaker declared a $3.5 billion acquisition in the United States last year, intended to enhance its research and development (R&D) and product development abilities by the end of 2026.<\/p>\n\n\n\n The company re-engages with the trade organization as pharmaceutical firms get ready to tackle possible tariffs and drug import fees during President Donald Trump's administration<\/a>.<\/p>\n\n\n\n \"We are also expanding our presence in the United States with significant investments in research, development and manufacturing,\" said Pascal Soriot, AstraZeneca\u2019s Chief Executive Officer.<\/p>\n\n\n\n Soriot stated that AstraZeneca is \"committed to collaborating with PhRMA and policymakers to maintain the U.S. as a global authority in biomedical innovation while ensuring that medicines are affordable for all who need them.\" In May 2023, the London-based company chose to exit the group and pursue different advocacy strategies at both state and federal levels.<\/p>\n\n\n\n The Pharmaceutical Research and Manufacturers of America (PhRMA) is the country's largest trade association of major drug manufacturers, based in Washington, D.C. Founded in 1958, PhRMA has been one of the most powerful lobbying groups in the nation, working on behalf of the pharmaceutical sector across a broad spectrum of policy matters.<\/p>\n\n\n\n PhRMA has persistently lobbied against federal and state initiatives to set drug price caps, enhance price transparency, or permit Medicare to negotiate prices. PhRMA contends that price controls would suppress innovation and lower the incentive for research and development, although critics point out that drug companies spend more on marketing than on research. <\/p>\n\n\n\n PhRMA also justifies robust patent protections and has resisted global attempts to waive intellectual property rights, including during the COVID-19 pandemic, on the grounds that waivers would destroy innovation and global health responses.<\/p>\n\n\n\n PhRMA has recently conducted high-profile ad campaigns and lobbying efforts to drive reforms against PBMs, who they characterize as \"middlemen\" that cause drug prices to be too high. The efforts are designed to get more savings<\/a> to patients and provide more transparency in the supply chain of drugs. PhRMA spent about $31.7 million in federal lobbying during 2024, ranking among the highest spending of all industries. The group hires several lobbying firms on a regular basis and employs large resources to shape legislation and regulation.<\/p>\n","post_title":"AstraZeneca rejoins major US pharmaceutical lobby after two years away","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"astrazeneca-rejoins-major-us-pharmaceutical-lobby-after-two-years-away","to_ping":"","pinged":"","post_modified":"2025-04-26 20:06:48","post_modified_gmt":"2025-04-26 20:06:48","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7624","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7610,"post_author":"7","post_date":"2025-04-25 18:31:16","post_date_gmt":"2025-04-25 18:31:16","post_content":"\n The surge of far-right political groups in Eastern Europe has been a worrying factor for financiers in the past, but Romania's political intrigue at present could be a breakthrough. Alliance for Romania (AUR) leader George Simion has become the center of a scandal over a contested \u20ac1.5 million lobbying contract with U.S. company BGD Legal and Consulting. <\/p>\n\n\n\n The charges\u2014disavowed by AUR\u2014present troubling inquiries about foreign interference, transparency, and Romania's democratic stability. For investors, this is not just a political circus: it's an indicator of vulnerabilities in a nation where the far-right holds 30% of the national legislature and has major economic clout.<\/p>\n\n\n\n The alleged deal with BGD Legal, entered into mere days before Simion's April 2025 U.S. visit, purportedly was meant to garner the endorsement of US far-right pundits such as Steve Bannon and activist Jack Posobiek. The company\u2019s connection to George Birnbaum, a strategist with ties to Viktor Orb\u00e1n's anti-globalist election initiatives in Hungary, provides a cross-border character to the scandal. Opponents claim the contract\u2014financed by Romanian state funds allocated to parliamentary groups\u2014is an abuse of public money. AUR refutes the existence of the agreement, stating its<\/a> U.S. costs were negligible and fair.<\/p>\n\n\n\n Simion's adamant support of the Tate brothers, who are on trial for rape and human trafficking, intensified heightened uncertainties. AUR's connections to Mateea Petrescu, the Tates' director of communications, and political analyst Anatol Lieven's attendance at a high-profile gathering with Simion highlight the intersection between domestic politics and global far-right webs. For businesspeople, this is a red flag: how will Romania's judiciary and political system navigate populist forces and the rule of law? The Tate case alone has attracted worldwide engagement, with NGOs caution about systemic corruption within the criminal justice system, a problem that can discourage foreign direct investment (FDI).<\/p>\n\n\n\n Romania's economy, which expanded by 4.6% in 2023, is now experiencing challenges. The increase of AUR has already initiated discussions surrounding fiscal approach, with Simion calling for anti-globalist policies such as raising the tax burden on foreign firms. In the meantime, the scandal has rekindled debate surrounding the accountability of public expenditures, which is a key consideration for investors betting on sound regulatory environments.<\/p>\n\n\n\n The BVB Index's volatility in 2024, down 12% from its 2023 high, suggests investor jitters. Political uncertainty, coupled with EU criticism of Romania's judicial reforms, may further test investor trust. Transparency International's Corruption Perceptions Index, which placed Romania 65th in the world in 2023 (out of 180 nations), already presents a warning sign.<\/p>\n","post_title":"\u20ac1.5M US lobbying controversy embroils far-right Romanian leader George Simion","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"e1-5m-us-lobbying-controversy-embroils-far-right-romanian-leader-george-simion","to_ping":"","pinged":"","post_modified":"2025-04-26 18:50:37","post_modified_gmt":"2025-04-26 18:50:37","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7610","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7609,"post_author":"7","post_date":"2025-04-25 18:31:14","post_date_gmt":"2025-04-25 18:31:14","post_content":"\n In January 2025, it was revealed that South Korean conglomerates had raised their lobbying expenditures in the US during the previous year, with Samsung at the forefront, spending almost $7 million. These increasing lobbying efforts in the world\u2019s largest economy seem to be a reaction to shifts in US approaches, including the CHIPS and Science Act and the Inflation Reduction Act, while also gearing up for the forthcoming Trump government.<\/p>\n\n\n\n Government lobbying by nations and corporations is a routine affair in the USA. The clique of lobbyists <\/a>is well awarded for making sure that the objectives of their clients are safeguarded before the global economic giant.<\/p>\n\n\n\n It's not surprising, therefore, that Samsung is among other large tech firms to engage in lobbying. Statistics from OpenSecrets, a research organization that monitors money coming into US politics, show that Samsung spent $5.45 million lobbying the US government alone last year.<\/p>\n\n\n\n Samsung Electronics America collectively shelled out $5.45 million in 2024 in lobbying expenditures. Other Samsung companies also used lobbyists, including Samsung Semiconductor at a cost of $860,000 and Samsung SDI America for $610,000. Collectively, the Samsung group had a total expenditure on lobbying to the tune of $6.98 million.<\/p>\n\n\n\n If that sounds excessive, a bit of viewpoint will clarify. Apple invested $7.82 million in its lobbying activities in 2024. Compared to the combined total expenditures by all Samsung <\/a>businesses, it was still less than what Apple invested in defending and advancing its agenda.<\/p>\n\n\n\n Samsung's expenditures are over twice those of its<\/a> principal foundry competitor, TSMC, which incurred $3.01 million. That gap is simply due to the reality that TSMC is solely in the relations of producing chips and doesn't have a consumer product selling business. Samsung is a large multinational corporation with numerous business divisions that sell goods straight to U.S. consumers like home devices, mobile phones, TVs, laptops, and more.<\/p>\n\n\n\n It is more exposed to the terms of trade policy, such as tariffs, that would have a substantial effect on the company's operations. Therefore, it is logical that Samsung would hold a relatively more significant lobbying expenditure than TSMC.<\/p>\n","post_title":"Samsung leads surge in lobbying amid shifting U.S. industrial policy","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"samsung-leads-surge-in-lobbying-amid-shifting-u-s-industrial-policy","to_ping":"","pinged":"","post_modified":"2025-04-26 18:46:03","post_modified_gmt":"2025-04-26 18:46:03","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7609","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"}],"next":false,"prev":true,"total_page":41},"paged":1,"column_class":"jeg_col_2o3","class":"epic_block_3"};
The recommendations aim to address a regulatory process at the SEC described in the report as \u201cinconsistent, opaque, and unpredictable.\u201d Additionally, it focuses on unaccountable proxy advisory companies that<\/a> significantly influence vote outcomes and corporate governance. BRT emphasized the need for broader structural reforms to shield investors and to ensure that US capital markets remain a catalyst for economic growth and opportunity.\u00a0<\/p>\n","post_title":"US lobby group calls for reform of outdated proxy voting systems","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"us-lobby-group-calls-for-reform-of-outdated-proxy-voting-systems","to_ping":"","pinged":"","post_modified":"2025-04-26 19:58:17","post_modified_gmt":"2025-04-26 19:58:17","post_content_filtered":"","post_parent":0,"guid":"https:\/\/dctransparency.com\/?p=7623","menu_order":0,"post_type":"post","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":7624,"post_author":"7","post_date":"2025-04-26 19:55:57","post_date_gmt":"2025-04-26 19:55:57","post_content":"\n AstraZeneca has reentered the primary U.S. pharmaceutical lobby group nearly two years after its exit, according to the Pharmaceutical Research and Manufacturers of America (PhRMA). This move comes after the British drugmaker declared a $3.5 billion acquisition in the United States last year, intended to enhance its research and development (R&D) and product development abilities by the end of 2026.<\/p>\n\n\n\n
\n
\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
The Andrew Tate link: A measure for governance<\/h2>\n\n\n\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
The Andrew Tate link: A measure for governance<\/h2>\n\n\n\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
The lobbying agreement: A controversial framework<\/h2>\n\n\n\n
The Andrew Tate link: A measure for governance<\/h2>\n\n\n\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
The lobbying agreement: A controversial framework<\/h2>\n\n\n\n
The Andrew Tate link: A measure for governance<\/h2>\n\n\n\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
The lobbying agreement: A controversial framework<\/h2>\n\n\n\n
The Andrew Tate link: A measure for governance<\/h2>\n\n\n\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
The lobbying agreement: A controversial framework<\/h2>\n\n\n\n
The Andrew Tate link: A measure for governance<\/h2>\n\n\n\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
The lobbying agreement: A controversial framework<\/h2>\n\n\n\n
The Andrew Tate link: A measure for governance<\/h2>\n\n\n\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
The lobbying agreement: A controversial framework<\/h2>\n\n\n\n
The Andrew Tate link: A measure for governance<\/h2>\n\n\n\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
The lobbying agreement: A controversial framework<\/h2>\n\n\n\n
The Andrew Tate link: A measure for governance<\/h2>\n\n\n\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
The lobbying agreement: A controversial framework<\/h2>\n\n\n\n
The Andrew Tate link: A measure for governance<\/h2>\n\n\n\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
The lobbying agreement: A controversial framework<\/h2>\n\n\n\n
The Andrew Tate link: A measure for governance<\/h2>\n\n\n\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
The lobbying agreement: A controversial framework<\/h2>\n\n\n\n
The Andrew Tate link: A measure for governance<\/h2>\n\n\n\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
The lobbying agreement: A controversial framework<\/h2>\n\n\n\n
The Andrew Tate link: A measure for governance<\/h2>\n\n\n\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
The lobbying agreement: A controversial framework<\/h2>\n\n\n\n
The Andrew Tate link: A measure for governance<\/h2>\n\n\n\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
The lobbying agreement: A controversial framework<\/h2>\n\n\n\n
The Andrew Tate link: A measure for governance<\/h2>\n\n\n\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
The lobbying agreement: A controversial framework<\/h2>\n\n\n\n
The Andrew Tate link: A measure for governance<\/h2>\n\n\n\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
The lobbying agreement: A controversial framework<\/h2>\n\n\n\n
The Andrew Tate link: A measure for governance<\/h2>\n\n\n\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n
The lobbying agreement: A controversial framework<\/h2>\n\n\n\n
The Andrew Tate link: A measure for governance<\/h2>\n\n\n\n
Political risk in relation to the Romanian economy<\/h2>\n\n\n\n
Samsung continues to invest less than Apple in lobbying the US government<\/h2>\n\n\n\n
\n